FDA Drug · D-0170-2026

Lantiseptic, Skin Protectant, Lanolin USP 30%, packaged in a) 5g (0.17 oz) (NDC 61924-304-05), b)14.2g (0.5 oz)( NDC 61924-304-14), c) 4oz (NDC 61924-304-04), d) 4.5oz (NDC 61924-304-45), and e) 12oz (NDC 61924-304-12) tubes, DermaRite Industries LLC, 7777 West Side Avenue, North Bergen, NJ 07047.

Class II · Ongoing

CGMP Deviation; manufactured at the same facility where other products and lots were found to be contaminated.

Affected lots / codes — check yours against thisAll lots on or before expiry date 08/2027

Recalling firm: DermaRite Industries, LLC, North Bergen, NJ
Classification: Class II (temporary or reversible harm possible)
Status: Ongoing
Quantity: 57,837 units
Distribution: Nationwide in the USA
Recall initiated: August 27, 2025
Classified: November 20, 2025
Initiation: Voluntary: Firm initiated

Official source. This record is published by the U.S. FDA through the openFDA enforcement database. View the unmodified government record:
https://api.fda.gov/drug/enforcement.json?search=recall_number%3A%22D-0170-2026%22

Important. Recalls target specific lots and codes — compare the affected lots above against your own product. This page reproduces public FDA data for readability; EveryRecall is independent and not affiliated with the FDA.

See every recall for this brand: Is DermaRite Industries, LLC recalled? →

Check this brand across all 8 databases →